Indian Institute Of Integrative Medicine Tender
Search from the latest JKtenders and find a business opportunity fitting your SME on the online platform of BidAssist. If you're wondering how to find the latest JK tenders or from where to get all the documents without the hassles, this is what we explain here. Find the best opportunities coming to the surface via the JK government, PSUs and state corporations.
Indian Institute Of Integrative Medicine - IIIM Tender
Healthcare and Medicine
Chemical Products
Eprocure
Opening Date24 Nov 2021
Closing Date14 Dec 2021
Tender AmountRefer Documents
Costs
EMD
Refer DocumentsDocument Cost
Refer DocumentsTender Fee
Refer Documents
Description
Scription for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user this is tender description for unregistered user
Contact
Tender Id
2021_CSIR_95971_1Bid Award Id
ViewTender No
12(321)/2021-PTender Authority
Indian Institute Of Integrative Medicine ViewPurchaser Address
-Website
http://https://www.csir.res.in/
GEM & Bid Advisory Services
Get portal registration, tender bidding, product/service listing or vendor/MSME certification services at a nominal cost
Documents
BOQ Items
... More
Product- II, Acute Toxicology Studies (Two Species: Mice and Rat) Acute single dose oral toxicity of Phytopharmaceutical lead (Product- II) in mice and rat by oral route as per Appendix III of Schedule Y (GLP study). Report of study should include all results, raw data, interpretations, observations, conclusions.
1
-
-
... More
STUDY-3
-
-
-
... More
Product- II, 10 days Dose ranging finding (DRF) studies 10-days dose-range finding (DRF) study (non-GLP study) of Phytopharmaceutical lead (Product- II ) in rat to identify a dose-range for 28-days repeated dose toxicity study
1
-
-
... More
STUDY-4
-
-
-
... More
Product- II, Sub Acute Toxicology Studies (28 days) in rat 28-days repeated dose oral toxicity study of Phytopharmaceutical lead (Product- II) in rat as per Appendix III of Schedule Y (GLP study) Report of study should include all results, raw data, interpretations, observations, conclusions.
1
-
-
Evaluation Notes How It Works ?
Potential Partner
Select Your Requirements